A long-forgotten “secret” remedy from the seas around New Zealand
gives new hope to people with joint aches and pain

Is this  2-minute trick

the solution for joint pain
that you have hoped for?

Scientists in New Zealand already uncovered this secret 50 years ago…
Why does your doctor not tell you about it?

Please give the Video a short period of time to load

Only for a short period:

With each order, you’ll receive a high-quality BodyFokus shaker FREE OF CHARGE!

You’ll discover strategies and secrets, for example …

a long-forgotten “secret” remedy from New Zealand to fight joint aches and pain, already discovered by scientists more than 50 years ago.
why painkillers can make your situation even worse, may even lead to more pain, and what the pharma industry doesn’t tell you.
the 1 simple trick that enables you to fight the pain in your joints once and for all, in just 2 minutes per day – without expensive painkillers from the pharmacy.
what the WORST type of food is for you, because it increases the pain in your joints, although it is frequently even praised as “healthy”, and you probably consume it every day.

… and much more!

Please watch the entire video, because I’ll only reveal the best piece of information at the very end!

List of studies

  • Deutsche Gesellschaft für Rheumatologie e.V. (2015): Rheuma in Zahlen. Betroffene Menschen in Deutschland. (Rheumatism statistics: people affected in Germany)


  • Coxib and traditional NSAID Trialists’ (CNT) Collaboration (2013): Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet, 382(9894): 769-779.


  • Johnson, AG., Nguyen TV, Day, RO. (1994): Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis., Annals of internal medicine, 121(4): 289-300.


  • Leong, RW., Chan, FK. (2006): Drug-induced side effects affecting the gastrointestinal tract. Expert Opin Drug Saf, 5(4): 585-592.


  • Sostres, C., Gargallo, CJ., Arroyo, MT., Lanas, A. (2010): Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol., Apr 2019, 24(2): 121-132.


  • Zittlau J., (2015): Was Paracetamol, Ibuprofen & Co gefährlich macht. Die Welt. (The dangers of paracetamol, ibuprofen & Co.)


  • Coulson, S., Vecchio, P., Gramotnev, H., Vitetta, L. (2012): Green-lipped mussel (Perna canaliculus) extract efficacy in knee osteoarthritis and improvement in gastrointestinal dysfunction: a pilot study. Inflammapharmacology, 20(2): 71-76.


  • Pollard, B., Guilford, WG., Ankenbauer-Perkins, KL., Hedderley, D. (2006): Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease. N Z Vet J, 54(3): 114-118.


  • Cayzer, J., Hedderley, D., Gray, S. (2012): A randomised, double-blinded, placebo-controlled study on the efficacy of a unique extract of green-lipped mussel (Perna canaliculus) in horses with chronic fetlock lameness attributed to osteoarthritis. Equine Vet J, 44(4): 393-398.


  • Wegener, T. (2002): Degenerative diseases of the musculoskeletal system--overview of current clinical studies of Devil's Claw (Harpagophyti radix)., Wien Med Wochenschr, 152(15-16): 389-92.


  • Gagnier, JJ., Chrubasik, S., Manheimer, E. (2004): Harpagophytum procumbens for osteoarthritis and low back pain: a systematic review. BMC Complement Altern Med, 4:13.


  • Wegener ,T., Lüpke, NP. (2003): Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC.), Phytother Res, 17(10): 1165-1172.


  • Torres-Fuentes, C., Theeuwes, WF., McMullen, MK., McMullen, AK., Dinan, TG., Cryan, JF., Schellekens, H. (2014): Devil's Claw to suppress appetite--ghrelin receptor modulation potential of a Harpagophytum procumbens root extract, PloS One, 9(7): e103118.


  • Cameron, M., Chrubasik, S. (2014): Oral herbal therapies for treating osteoarthritis. Cochrane Database Syst Rev, 5: CD002947.


  • Kimmatkar, N., Thawani, V., Hingorani, L., Khiyani, R. (2003): Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee - a randomized double blind placebo controlled trial. Phytomedicine, 10(1): 3-7.


  • Reginster, JY., Neuprez, A., Lecart, MP., Sarlet, N., Bruyere, O. (2012): Role of glucosamine in the treatment for osteoarthritis. Rheumatol Int, 32(10): 2959–2967.


  • Pavelká, K., Gatterová, J., Olejarová, M., Machacek, S., Giacovelli, G., Rovati, LC. (2002): Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med, 162(18): 2113-2123.


  • Clegg, DO., Reda, DJ., Harris, CL. et al. (2006): Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis, N Engl J Med, 354(8): 795-808.


  • Bello, AE., Oesser, S. (2006): Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature. Curr Med Res Opin, 22(11): 2221-2232.


  • Tashiro, T., Seino, S., Sato, T., Matsuoka, R., Masuda, Y., Fukui, N. (2012): Oral Administration of Polymer Hyaluronic Acid Alleviates Symptoms of Knee Osteoarthritis: A Double-Blind, Placebo-Controlled Study over a 12-Month Period. Scientific World Journal, 2012: 167928.


  • Kim, LS., Axelrod, LJ., Howard, ND., Buratovich, N., Waters, RF. (2006): Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage, 14(3): 286-294.


  • Usha, PR., Naidu, MU. (2004): Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in Osteoarthritis. Clinical Drug Invest, 24(6): 353-363.


  • Chen, LH. (1989): Interaction of vitamin E and ascorbic acid (review). In Vivo, 3(3):199-209.


  • Schuppan, D., Pickert, G., Ashfaq-Khan, M., Zevallos, V. (2015): Non-celiac wheat sensitivity: differential diagnosis, triggers and implications. Best Pract Res Clin Gastroenterol, 29(3): 469-476.


Our site uses cookies for analytical and promotional purposes and more generally, to improve your experience on our website. By visiting this site, you are agreeing to our privacy policy regarding the use of cookies on this site.